Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study
Kathrin Kirchheiner(Comprehensive Cancer Center Vienna), Kari Tanderup(Aarhus University), Peter Hoskin(University of Manchester), Remi A. Nout(Erasmus MC Cancer Institute), Ina M. Jürgenliemk‐Schulz(University Medical Center Utrecht), Jacob Christian Lindegaard(Aarhus University Hospital), Barbara Šegedin(Institute of Oncology Ljubljana), Christine Haie-Méder(Institut Gustave Roussy), Christian Kirisits(Comprehensive Cancer Center Vienna), Richard Pötter(Medical University of Vienna), Søren M. Bentzen(University of Wisconsin–Madison), Bhavana Rai(Post Graduate Institute of Medical Education and Research), Wolfgang Dörr(Goethe University Frankfurt), Umesh Mahantshetty(Homi Bhabha National Institute)
Cited by 214
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
|Radiotherapy and Oncology|2006|1.6k
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
|Radiotherapy and Oncology|2005|1.5k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k